Discover
MYGN
Myriad Genetics, Inc.
6.00
2 x 4.32
2 x 7.33
bid
ask
+
0.29
5.08%
2 @ 05:07 AM
5.90 -0.10 (1.67%)
| Ytd | -2.44% | |
| 1y | 8.50% |
5.72
day range
6.00
3.53
52 week range
8.59
| Open | 5.73 | Prev Close | 5.71 | Low | 5.72 | High | 6.00 | Mkt Cap | 566.69M |
| Vol | 1.63M | Avg Vol | 1.63M | EPS | -4.31 | P/E | N/A | Forward P/E | 71.53 |
| Beta | 1.89 | Short Ratio | 4.83 | Inst. Own | 103.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 4.50 | 200-d Avg | 5.80 | 1yr Est | 19.41 |
| Income Statement | |||
| Total Revenue | 200.40M | ||
| Revenues (USD) | 200.40M | ||
| Cost of Revenue | 62.80M | ||
| Gross Profit | 137.60M | ||
| Operating Expenses | 168.30M | ||
| Research and Development Expense | 27.10M | ||
| Selling, General and Administrative Expense | 135.80M | ||
| Operating Income | -30.70M | ||
| Interest Expense | 4.10M | ||
| Net Income | -34.10M | ||
| Net Income Common Stock | -34.10M | ||
| Net Income Common Stock (USD) | -34.10M | ||
| Consolidated Income | -34.10M | ||
| Earnings per Basic Share | -0.36 | ||
| Earnings per Basic Share (USD) | -0.36 | ||
| Earnings per Diluted Share | -0.36 | ||
| Earning Before Interest & Taxes (EBIT) | -30.00M | ||
| Earning Before Interest & Taxes (USD) | -30.00M | ||
| Weighted Average Shares | 93.70M | ||
| Weighted Average Shares Diluted | 93.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 124.40M | ||
| Cash and Equivalents (USD) | 124.40M | ||
| Trade and Non-Trade Receivables | 123.80M | ||
| Current Assets | 312.80M | ||
| Property, Plant & Equipment Net | 162.50M | ||
| Total Assets | 673.70M | ||
| Debt Current | 7.10M | ||
| Total Debt | 211.50M | ||
| Current Liabilities | 130.20M | ||
| Debt Non-Current | 204.40M | ||
| Total Liabilities | 336.30M | ||
| Accumulated Retained Earnings (Deficit) | -1.16B | ||
| Accumulated Other Comprehensive Income | 700.00K | ||
| Shareholders Equity | 337.40M | ||
| Shareholders Equity (USD) | 337.40M | ||
| Assets Non-Current | 360.90M | ||
| Total Debt (USD) | 211.50M | ||
| Goodwill and Intangible Assets | 192.80M | ||
| Inventory | 27.90M | ||
| Liabilities Non-Current | 206.10M | ||
| Trade and Non-Trade Payables | 32.60M | ||
| Tax Assets | 2.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 13.50M | ||
| Net Cash Flow from Financing | -3.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -25.30M | ||
| Capital Expenditure | -6.50M | ||
| Issuance (Repayment) of Debt Securities | -100.00K | ||
| Net Cash Flow from Investing | -6.50M | ||
| Net Cash Flow from Operations | -15.70M | ||
| Effect of Exchange Rate Changes on Cash | -100.00K | ||
| Share Based Compensation | 6.50M | ||